NEW YORK (GenomeWeb News) – Roche's Ventana Medical Systems today announced a collaboration to develop companion diagnostics for Incyte's oncology drug programs.

The first test will be developed for Incyte's ID01 inhibitor program, Ventana said, adding it will support Incyte's efforts using its expertise in companion diagnostics, immunohistochemistry technology platforms, and customer support.

Financial and other terms of the deal were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: human cytomegalovirus diversity, patterns of homologous recombination in E. coli, and more.

US lawmakers are considering eliminating the medical devices tax that is part of the Affordable Care Act.

Two research teams in China home in on a gene that gives rice a long, slender shape.

Marcia McNutt, the editor-in-chief of Science, has been nominated to become president of the US National Academy of Sciences.